Profit Or Loss [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166293

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
3,096 EUR
175,000 EUR
Cost of sales
107,000 EUR
145,000 EUR
Gross profit
2,988 EUR
30,000 EUR
Other expense, by function
0 EUR
1,468 EUR
Profit (loss) from operating activities
10,541 EUR
7,025 EUR
Finance income
32,000 EUR
901,000 EUR
Finance costs
773,000 EUR
1,021 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
191,000 EUR
Profit (loss) before tax
11,282 EUR
7,145 EUR
Tax expense (income)
297,000 EUR
1,000 EUR
Profit (loss)
11,579 EUR
7,145 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
11,579 EUR
7,145 EUR
Profit (loss), attributable to non-controlling interests
- EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
45.00
33.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.